Drug discovery market was valued at $71.8 billion in 2025 and is projected to reach $178.06 billion by 2035, growing at a CAGR of 9.6% during the forecast Period (2026-2035). The growth of the drug discovery market is driven by the increasing need for therapeutic solutions across healthcare sectors, where the prevalence of chronic and infectious diseases requires ongoing research activity. The demand for faster identification of drug candidates, improved efficacy, and reduced development timelines has led to wider use of advanced discovery tools and platforms. Market activity is influenced by technological developments in high-throughput screening, computational drug design, and artificial intelligence, as well as the emphasis on reducing clinical attrition through data-driven early-stage research.
Browse the full report description of “Drug Discovery Market Size, Share & Trends Analysis By Type (Pharmacogenomics, High Throughput Screening, Genomics, Bioinformatics, Biochips and Nanotechnology), and By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Biotech Companies and Research Institutes), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/drug-discovery-market
In the United States, regulatory and funding frameworks influence drug discovery by defining research priorities and providing support for the development of new therapeutics. Policies such as the Food and Drug Administration’s (FDA) expedited review pathways and public funding for biomedical research affect the progression of discovery efforts. Compliance with regulatory requirements for preclinical validation and safety assessment is necessary for the development of drug candidates and guides the implementation of automated and scalable discovery workflows.
In Europe, programs including Horizon Europe and regional research grants support activities related to target identification, disease modeling, and candidate optimization. Countries such as the United Kingdom, Germany, and France have established funding mechanisms and collaborative research networks that facilitate coordination between academic institutions and industry. Policy frameworks, technological development, and research investment collectively influence the growth of the drug discovery market.
Key Drivers Shaping the Drug Discovery Market
The key players in the global drug discovery market include AbbVie, Johnson & Johnson, Merck & Co., Pfizer, Roche, among others. These companies are engaged in research and development of novel therapeutics, early-stage drug discovery programs, and pipeline expansion across multiple disease areas. Their activities include collaborations and licensing agreements to advance investigational compounds, development of small molecules, biologics, and RNA-based therapeutics, and application of advanced technologies such as high-throughput screening, artificial intelligence, and molecular modeling to accelerate drug discovery and preclinical development.
Market Coverage
Key questions addressed by the report.
Drug discovery market Report Segment
By Type
By End-Users
Drug discovery market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/drug-discovery-market